What's Going On With Bone Biologics Corp Stock?
Portfolio Pulse from Erica Kollmann
Bone Biologics Corp (NASDAQ:BBLG) stock is experiencing high volatility and multiple trading halts without company-specific news. The stock underwent a 1-for-8 reverse split on Dec. 20 and closed a direct offering on Nov. 20. With a small float and high short interest, BBLG is moving with other small cap pharmaceutical stocks like ZJYL, TTOO, and IOVA. BBLG's borrow fee rate is 91.79%, and no shares are available to short. The stock is up 31% at $6.10.
December 28, 2023 | 6:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Iovance Biotherapeutics, Inc. is mentioned as moving along with Bone Biologics and other small cap pharmaceutical stocks.
IOVA is grouped with BBLG as part of a sector movement, but there is no specific news about IOVA to suggest a direct impact on its stock price.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
T2 Biosystems, Inc. is mentioned as moving along with Bone Biologics and other small cap pharmaceutical stocks.
TTOO is mentioned as moving with BBLG, but without specific news or data about TTOO, the impact on its stock price is uncertain.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Jin Medical International, Ltd. is mentioned as moving along with Bone Biologics and other small cap pharmaceutical stocks.
While ZJYL is mentioned as moving with BBLG, there is no specific news or data provided about ZJYL that would suggest a direct impact on its stock price.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Bone Biologics Corp's stock is trading higher with significant volatility and has been halted multiple times. The company recently completed a reverse stock split and a direct offering.
The high volatility and trading halts, combined with the recent reverse split and direct offering, suggest a potential for continued short-term price increases, especially given the small float and high short interest.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100